UC Davis Genome Center, Department of Biochemistry and Molecular Medicine, Pharmacology,
MIND Institute,
UC Davis School of Medicine
Visit Website
Specialty: Genomic therapeutics
Department of Psychiatry and Behavioral Sciences; University of California Davis School of Medicine
View Website
Speciality: preclinical translational evaluation of pharmacological treatments for autism spectrum disorders
Genetic Diagnosis Campaign in Argentina. Casa Angelman developed a National Genetic Campaign to provide testing for children across Argentina and with assistance from FAST, will be able to bridge that gap for many Argentinian families.
Read MoreGeneration and characterization of a new AS mouse model that recapitulates the large deletion of human 15q11-q13 and a control line that carries a deletion of all genes in 15q11-q13 but UBE3A Primary Investigator: Y. Jiang Dr. Jiang will create a novel ~6MB full deletion Angelman syndrome mouse model. As we near a therapeutic aimed […]
Read MoreUse of the Actimyo device for evaluation of tolerability and characterization of Angelman syndrome specific gait patterns. Primary Investigator: J. Duis Dr. Duis used the ActiMyo device(s) in a clinical study to evaluate the tolerability and gait parameters in Angelman syndrome. This device was shown to be well tolerated and associated with various unique gait […]
Read More